Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000772984 | SCV000906366 | likely benign | Hereditary cancer-predisposing syndrome | 2018-05-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001477436 | SCV001681679 | likely benign | Fanconi anemia complementation group O | 2024-03-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000772984 | SCV002634808 | likely benign | Hereditary cancer-predisposing syndrome | 2020-12-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003456427 | SCV004184695 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | RAD51C: PM2:Supporting, BP4, BP7 |